Login / Signup

Major Update 2: Antibody Response and Risk for Reinfection After SARS-CoV-2 Infection-Final Update of a Living, Rapid Review.

Haley K HolmerKatherine MackeyCelia V FiordalisiMark Helfand
Published in: Annals of internal medicine (2022)
Agency for Healthcare Research and Quality. (PROSPERO: CRD42020207098).
Keyphrases
  • healthcare
  • respiratory syndrome coronavirus
  • drug administration
  • breast cancer risk